THE MODE OF ACTION OF ANTIBIOTICS IN STIMULATING GROWTH OF CHICKS

Enhancing the antimicrobial activity of silver nanoparticles against ESKAPE bacteria and emerging fungal pathogens by using tea extracts

The sale of antibiotics and antifungals has skyrocketed since 2020. The increasing threat of pathogens like ESKAPE bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.), which are effective in evading existing antibiotics, and yeasts like Candida auris or Cryptococcus neoformans is pressing to develop efficient antimicrobial alternatives. Nanoparticles, especially silver nanoparticles (AgNPs), are believed to be promising candidates to supplement or even replace antibiotics in some applications. Here, we propose a way to increase the antimicrobial efficiency of silver nanoparticles by using tea extracts (black, green, or red) for their synthesis. This allows for using lower concentrations of nanoparticles and obtaining the antimicrobial effect in a short time. We found that AgNPs synthesized using green tea extract (G-TeaNPs) are the most effective, causing approximately 80% bacterial cell death in Gram-negative bacteria within only 3 hours at a concentration of 0.1 mg mL-1, which is better than antibiotics. Ampicillin at the same concentration (0.1 mg mL-1) and within the same duration (3 h) causes only up to 40% decrease in the number of S. aureus and E. cloacae cells (non-resistant strains). The tested silver nanoparticles also have antifungal properties and are effective against C. auris and C. neoformans, which are difficult to eradicate using other means. We established that silver nanoparticles synthesized with tea extracts have higher antibacterial properties than silver nanoparticles alone. Such formulations using inexpensive tea extracts and lower concentrations of silver nanoparticles show a promising solution to fight various pathogens.

Pioneer colonizers: Bacteria that alter the chicken intestinal morphology and development of the microbiota

Microbes commonly administered to chickens facilitate development of a beneficial microbiome that improves gut function, feed conversion and reduces pathogen colonization. Competitive exclusion products, derived from the cecal contents of hens and shown to reduce Salmonella colonization in chicks, possess important pioneer-colonizing bacteria needed for proper intestinal development and animal growth. We hypothesized that inoculation of these pioneer-colonizing bacteria to day of hatch chicks would enhance the development of their intestinal anatomy and microbiome. A competitive exclusion product was administered to broiler chickens, in their drinking water, at day of hatch, and its impact on intestinal morphometrics, intestinal microbiome, and production parameters, was assessed relative to a control, no treatment group. 16S rRNA gene, terminal restriction fragment length polymorphism (T-RFLP) was used to assess ileal community composition. The competitive exclusion product, administered on day of hatch, increased villus height, villus height/width ratio and goblet cell production ∼1.25-fold and expression of enterocyte sugar transporters 1.25 to 1.5-fold in chickens at 3 days of age, compared to the control group. As a next step, chicks were inoculated with a defined formulation, containing Bacteroidia and Clostridia representing pioneer-colonizing bacteria of the two major bacterial phyla present in the competitive exclusion product. The defined formulation, containing both groups of bacteria, were shown, dependent on age, to improve villus height (jejunum: 1.14 to 1.46-fold; ileum: 1.17-fold), goblet cell numbers (ileum 1.32 to 2.51-fold), and feed efficiency (1.18-fold, day 1) while decreasing Lactobacillus ileal abundance by one-third to half in birds at 16 and 42 days of age, respectively; compared to the phosphate buffered saline treatment group. Therefore, specific probiotic formulations containing pioneer colonizing species can provide benefits in intestinal development, feed efficiency and body weight gain.

A synergistic effect of hydrophobic deep eutectic solvents based on terpenoids and carboxylic acids for tetracycline microextraction

Microextraction of tetracyclines in hydrophobic terpenoid-based deep eutectic solvents for the HPLC-DAD determination of tetracyclines in milk.

Crosstalk between the growth hormone/insulin-like growth factor-1 axis and the gut microbiome: A new frontier for microbial endocrinology

Both the GH/IGF-1 axis and the gut microbiota independently play an important role in host growth, metabolism, and intestinal homeostasis. Inversely, abnormalities in GH action and microbial dysbiosis (or a lack of diversity) in the gut have been implicated in restricted growth, metabolic disorders (such as chronic undernutrition, anorexia nervosa, obesity, and diabetes), and intestinal dysfunction (such as pediatric Crohn's disease, colonic polyps, and colon cancer). Over the last decade, studies have demonstrated that the microbial impact on growth may be mediated through the GH/IGF-1 axis, pointing toward a potential relationship between GH and the gut microbiota. This review covers current research on the GH/IGF-1 axis and the gut microbiome and its influence on overall host growth, metabolism, and intestinal health, proposing a bidirectional relationship between GH and the gut microbiome.

Strategies to modulate the intestinal microbiota and their effects on nutrient utilization, performance, and health of poultry

Poultry is widely produced and consumed meat globally. Its demand is expected to continue increasing to meet the animal protein requirement for ever-increasing human population. Thus, the challenge that poultry scientists and industry face are to produce sufficient amount of poultry meat in the most efficient way. In the past, using antibiotics to promote the growth of poultry and manage gut microbiota was a norm. However, due to concerns over potential fatalistic impacts on food animals and indirectly to humans, their use as feed additives are banned or regulated in several jurisdictions. In this changed context, several alternative strategies have been proposed with some success that mimics the functions of antibiotics as growth promoters and modulate gut microbiota for their beneficial roles. These include the use of probiotics, prebiotics, organic acids, and exogenous enzyme, among others. Gut microbiota and their metabolic products improve nutrient digestion, absorption, metabolism, and overall health and growth performance of poultry. This paper reviews the available information on the effect of feed additives used to modulate intestinal microbiota of poultry and their effects on overall health and growth performance. Understanding these functions and interactions will help to develop new dietary and managerial strategies that will ultimately lead to enhanced feed utilization and improved growth performance of poultry. This review will help future researchers and industry to identify alternative feed ingredients having properties like prebiotics, probiotics, organic acids, and exogenous enzymes.

Antibiotic resistance: A current epilogue

The history of the first commercial antibiotics is briefly reviewed, together with data from the US and WHO, showing the decrease in death due to infectious diseases over the 20th century, from just under half of all deaths, to less than 10%. The second half of the 20th century saw the new use of antibiotics as growth promoters for food animals in the human diet, and the end of the 20th century and beginning of the 21st saw the beginning and rapid rise of advanced microbial resistance to antibiotics.

Structural aspects of phenylglycines, their biosynthesis and occurrence in peptide natural products

Phenylglycine-type amino acids occur in a wide variety of peptide natural products. Herein structures and properties of these peptides as well as the biosynthetic origin and incorporation of phenylglycines are discussed.

Review: Chinese herbs as alternatives to antibiotics in feed for swine and poultry production: Potential and challenges in application

Gong, J., Yin, F., Hou, Y. and Yin, Y. 2014. Chinese herbs as alternatives to antibiotics in feed for swine and poultry production: Potential and challenges in application. Can. J. Anim. Sci. 94: 223–241. Traditional Chinese medicine (TCM) has a long history of clinical practice, and its own theoretical framework focused on functions at the whole-body level. However, due to cultural differences, TCM has not been fully recognized in Western countries. With the recent development of the theory of whole-body systems biology and “-omics”, there is a new opportunity to study TCM and to close the gap between TCM and Western medicine, because of the similarity in the theoretical foundations between TCM and whole-body systems biology. The uniqueness of TCM theory and practice is the approach to maintain and restore the body balance as a whole with no or little unfavourable side effects. Recent studies have also shown that Chinese herbs used as feed additives can modulate nutritional metabolism, immune responses, and intestinal health of food-producing animals, demonstrating good potential as substitutes for dietary antibiotics. Nonetheless, some issues need to be addressed before Chinese herbs can reach their full application. This article has critically reviewed recent progresses in scientific research of Chinese herbs as feed additives and their potential to replace dietary antibiotics. Possible challenges in future application for swine and poultry production are also discussed.

Childhood malnutrition: toward an understanding of infections, inflammation, and antimicrobials

BACKGROUND

Undernutrition in childhood is estimated to cause 3.1 million child deaths annually through a potentiating effect on common infectious diseases, such as pneumonia and diarrhea. In turn, overt and subclinical infections, and inflammation, especially in the gut, alter nutrient intake, absorption, secretion, diversion, catabolism, and expenditure.

OBJECTIVE

A narrative overview of the current understanding of infections, inflammation, and antimicrobials in relation to childhood malnutrition.

METHODS

Searches for pivotal papers were conducted using PUBMED 1966-January 2013; hand searches of the references of retrieved literature; discussions with experts; and personal experience from the field.

RESULTS

Although the epidemiological evidence for increased susceptibility to life-threatening infections associated with malnutrition is strong, we are only just beginning to understand some of the mechanisms involved. Nutritional status and growth are strongly influenced by environmental enteric dysfunction (EED), which is common among children in developing countries, and by alterations in the gut microbiome. As yet, there are no proven interventions against EED. Antibiotics have long been used as growth promoters in animals. Trials of antibiotics have shown striking efficacy on mortality and on growth in children with uncomplicated severe acute malnutrition (SAM) or HIV infection. Antibiotics act directly by preventing infections and may act indirectly by reducing subclinical infections and inflammation. We describe an ongoing multicenter, randomized, placebo-controlled trial of daily cotrimoxazole prophylaxis to prevent death in children recovering from complicated SAM. Secondary outcomes include growth, frequency and etiology of infections, immune activation and function, the gut microbiome, and antimicrobial resistance. The trial is expected to be reported in mid-2014.

CONCLUSIONS

As well as improving nutritional intake, new case management strategies need to address infection, inflammation, and microbiota and assess health outcomes rather than only anthropometry.

THE EFFECT OF ANTIBACTERIAL DRUGS ON THE WEIGHT OF MICE

NCS mice gained weight rapidly when fed a gluten diet deficient in several amino acids, but their weight gain on the same regimen was very much retarded if they were given antibacterial drugs, even for a short period of time. This retardation of growth could not be entirely corrected by supplementing the gluten diet with lysine and threonine. The decrease in growth rate brought about by antibacterial drugs could probably be traced to the alteration in intestinal flora resulting from drug treatment. The intensity and duration of both types of changes were related to the dose of drug administered, and to the length of the treatment period. Whatever the nutritional regimen, treatment with penicillin caused a retardation of weight gain in NCS mice. The retardation was more pronounced, and longer lasting, when the animals were fed semisynthetic regimens (containing casein or gluten) than when they were fed crude diets (pellets) containing natural materials of ill defined composition. These differences probably had their origin in the fact that the changes in fecal flora induced by the drugs were profoundly influenced by the composition of the diet. Antibacterial drugs which retarded weight gain of Swiss NCS mice, in contrast increased weight gain in ordinary Swiss mice raised under usual conditions. It is probable that this difference in response to the antibacterial drugs resulted from the fact that ordinary Swiss mice have a much more complex intestinal flora than NCS animals.

Probiotic bile salt hydrolase: current developments and perspectives

Probiotic has modernized the current dietetic sense with novel therapeutic and nutritional benefits to the consumers. The presence of bile salt hydrolase (BSH) in probiotics renders them more tolerant to bile salts, which also helps to reduce the blood cholesterol level of the host. This review focuses on the occurrence of bile salt hydrolase among probiotics and its characterization, importance, applications, and genetics involved with recent updates. Research on bile salt hydrolase is still in its infancy. The current perspective reveals a huge market potential of probiotics with bile salt hydrolase. Intensive research in this field is desired to resolve some of the lacunae.

Effects of Copper Source and Level on Intestinal Physiology and Growth of Broiler Chickens

Dietary copper sulfate (CuSO4) and tribasic copper chloride (TBCC) were examined for their effects on intestinal physiology and growth of broiler chickens. In 2 experiments (Experiments 1 and 2), day-old broiler chicks were fed 1 of 4 diets: a basal diet with no supplemental copper (Cu; negative control), a basal diet + 188 mg of Cu/kg of diet from TBCC or CuSO4, or a basal diet + subtherapeutic antibiotics (bacitracin and roxarsone; positive control). In Experiment 1 (recycled litter), CuSO4 and TBCC increased carcass weight (d 45 posthatch) compared with the negative control (P < 0.05 for each). In Experiment 2 (fresh litter), negative control and TBCC increased carcass weight (d 42 posthatch) compared with the positive control (P < 0.05 for each). At d 30 to 31 posthatch, intestinal histology was measured. In Experiment 1 (recycled litter), dietary TBCC, CuSO4, and positive control decreased the number of lamina propia lymphocytes or intraepithelial lymphocytes (IEL), or both, compared with the negative control (P < 0.05). However, in Experiment 2 (fresh litter), TBCC and positive control increased the number of duodenum IEL compared with the negative control (P < 0.05), and negative control and TBCC increased the number of ileum IEL. These data demonstrate that broiler performance and intestinal physiology can be influenced by dietary Cu source and level as well as microbial environment (fresh vs. recycled litter).

Effects of virginiamycin and a mannanoligosaccharide-virginiamycin shuttle program on the growth and performance of large white female turkeys

Shuttle programs involving dietary supplementation of mannanoligosaccharides (MOS) and virginiamycin (VM) were evaluated in turkeys by their effects on growth performance, body weight uniformity, and carcass yield characteristics. Diets containing no growth promoter (control), VM (22 mg/kg), or a shuttle program (MOS-VM) of MOS (0 to 6 wk of age at 500 mg/ kg) and VM (6 to 14 wk of age at 22 mg/kg) were fed to Hybrid female turkeys. All diets were formulated to exceed NRC nutrient requirements. Each treatment was assigned to 8 replicate floor pens containing 20 birds that were reared from 1 to 98 d of age. Body weights and feed consumption were recorded at 3-wk intervals, and mortality and culled birds were recorded daily. At the conclusion of the trial, 2 birds per pen were randomly chosen for carcass yield analysis. Feeding VM alone significantly (P < 0.05) increased body weight compared with control fed birds during all periods. The MOS-VM shuttle program resulted in early growth depression for birds less than 3 wk of age, possibly influenced by an unplanned cold stress, but better growth than the nonmedicated control birds after 6 wk of age. Birds fed VM had superior (P < 0.05) feed conversion ratio from 0 to 3 wk, which persisted until 14 wk (P < 0.10). There were no treatment effects on overall feed consumption, uniformity, mortality, or cull rate. Processing yields or weight of various parts were also unaffected by treatment.

Effects of supplementation of beta-glucan on the growth performance and immunity in broilers

Two experiments were conducted to evaluate the efficacy of beta-glucan on commercial broilers. In experiment 1, one hundred and forty-four broiler chicks were employed in a 2x3 factorial design with cage and open floor housing with three levels of beta-glucan viz. 0%, 0.02% and 0.04%. In experiment 2, ninety-six broilers were used with 4 treatments: No beta-glucan and antibiotic (T1), beta-glucan 0.03% (T2), antibiotic (T3), and beta-glucan 0.03% + antibiotic (T4) for 34 d with 3 replicates of 8 chicks each in both studies. During experiment 1 there was no significant effect of the feeding system or the beta-glucan levels on the performance from 0 to 17 d but during 18-34 days birds housed on the open floor had significantly (p<0.0001) higher weight gain compared with those in cages. In experiment 2, no significant effect was noticed on the weight gains when the effect of beta-glucan, antibiotic or their interaction were tested. The retention of dry matter increased in both experiments with beta-glucan supplementation. The CD8 and TCR 1 cells were significantly higher in the 0.04% beta-glucan group at 42 days as compared with the control. It could be concluded that beta-glucan supplementation was beneficial for broilers.

Effects of mushroom and herb polysaccharides, as alternatives for an antibiotic, on the cecal microbial ecosystem in broiler chickens

An in vivo experiment was conducted to study the potential prebiotic effects of mushroom and herb polysaccharide extracts, Lentinus edodes extract (LenE), Tremella fuciformis extract, and Astragalus membranaceus Radix extract, on chicken growth and the cecal microbial ecosystem, as compared with the antibiotic Apramycin (APR). This investigation was carried out in terms of a dose-response study. The chickens were naturally infected with avian Mycoplasma gallisepticum prior to the experiment. The BW gain, cecal pH, viscosity, and predominant microbial populations were measured 1 wk after the extract and APR treatments. The extracts and APR significantly stimulated growth of the chickens infected with avian Mycoplasma gallisepticum. The average BW gain of the groups fed with the extracts was significantly lower than that of the antibiotic group. The extracts had no significant effect on cecal pH. However, cecal viscosity and microbial populations were significantly affected by feeding extracts and antibiotic. In contrast to APR, the extracts stimulated the number of the potentially beneficial bacteria (bifidobacteria and lactobacilli), while reducing the number of the potentially harmful bacteria (Bacteroides spp. and Escherichia coli). Of the 3 extracts, LenE was associated with the most cecal bifidobacteria and lactobacilli. With each increase in the LenE dose, birds tended to have higher BW gain and total aerobe and anaerobe counts. Numbers of predominant cecal bacteria, in particular, E. coli, bifidobacteria, and lactobacilli, were significantly increased with increases in the LenE dose. It would seem that these specific mushroom and herb polysaccharide extracts hold some promise as potential modifiers of intestinal microbiota in diseased chickens.

Rice expressing lactoferrin and lysozyme has antibiotic-like properties when fed to chicks

Two experiments were conducted to determine whether rice that has been genetically produced to express human lactoferrin (LF) or lysozyme (LZ) protects the intestinal tract similarly to subtherapeutic antibiotics (bacitracin + roxarsone; Antibiotics). Experiment 1 compared 10 corn-soy diets containing 20% of various proportions of LF, LZ or conventional rice (CONV). Chicks fed 5% LF + 10% LZ + 5% CONV had significantly better feed efficiency and thinner lamina propria in the duodenum than those fed 20% CONV. Experiment 2 compared five corn-soy diets containing experimental rice combinations totaling 15% rice. Chicks fed 10% LZ + 5% CONV or 5% LF + 10% LZ had significantly lower feed intake and significantly better feed efficiency than those fed 15% CONV. Chicks fed 10% LZ + 5% CONV, 5% LF + 10% LZ or Antibiotics had significantly greater villous height in the duodenum compared with chicks fed 15% CONV. The lamina propria of the ileum was thinner and contained fewer leukocytes in chicks fed 10% LZ + 5% CONV or Antibiotics compared with those fed 15% CONV. The results from these experiments demonstrate a potential of genetically produced LF and LZ rice to be used as a substitute for antibiotics in broiler diets.

Antibiotics as growth promotants: mode of action

Recent concerns about the use of growth-promoting antibiotics in pig diets have renewed interest in the immunologic and growth-regulating functions of the gastrointestinal (GI) tract. The numerically dense and metabolically active microbiota ofthe pig GI tract represents a key focal point for such questions. The intestinal microbiota is viewed typically as a beneficial entity for the host. Intestinal bacteria provide both nutritional and defensive functions for their host. However, the host animal invests substantially in defensive efforts to first sequester gut microbes away from the epithelial surface, and second to quickly mount immune responses against those organisms that breach epithelial defenses. The impact of host responses to gut bacteria and their metabolic activities require special consideration when viewed in the context of pig production in which efficiency of animal growth is a primary objective. Here, we summarize the working hypothesis that antibiotics improve the efficiency of animal growth via their inhibition of the normal microbiota, leading to increased nutrient utilization and a reduction in the maintenance costs ofthe GI system. In addition, novel molecular ecology techniques are described that can serve as tools to uncover the relationship between intestinal microbiology and growth efficiency.

Genes encoding bile salt hydrolases and conjugated bile salt transporters in Lactobacillus johnsonii 100-100 and other Lactobacillus species

Lactobacillus johnsonii strain 100-100 expresses two antigenically distinct conjugated bile salt hydrolases (BSH), alpha and beta, that combine to form native homo- and heterotrimers. This paper reports characterization of loci within the genome that encode this capacity. A locus that encodes BSH beta (cbsH beta), a partial (cbsT1) and a complete conjugated bile salt transporter (cbsT2) was identified previously. DNA sequence analysis at this locus was extended and revealed a complete ORF for cbsT1 and no other ORFs in tandem. The three genes, cbsT1, cbsT2 and cbsH beta, probably constitute an operon; a putative promoter was identified upstream of cbsT1. A second locus that expresses BSH activity in strain 100-100 was identified. Sequence analysis of the clone predicted a 978 nt ORF that did not share tandem organization with other ORFs, was similar in sequence to other BSH genes, and matched, in predicted protein sequence, the first 25 amino acids of BSH alpha. A phenotypic screen for BSH activity and a genetic screen for the cbsH beta locus were performed on 50 Lactobacillus isolates from humans or dairy products. Nearly all of the isolates that were positive for cbsH beta were from human sources. Variability in the BSH phenotype and cbsH beta genotype was identified in isolates of the same species. DNA sequence was obtained and analysed from the cbsH beta locus of one human isolate, L. acidophilus strain KS-13. This organism has cbsT1, cbsT2 and cbs beta genes that are 84, 87 and 85% identical in DNA sequence to those of strain 100-100. DNA sequence identity to strain 100-100 ends in regions flanking this locus. The findings of this study suggest that BSH genes have been acquired horizontally and that BSH activity is important at some level for lactobacilli to colonize the lower gastrointestinal tract.

Effects of feed antibiotic avoparcine on organ morphology in broiler chickens

Groups of 90 male broilers each were administered the antibiotic avoparcine mixed into feed in concentrations of 7.5, 10, and 15 ppm and achieved a higher mean body weight than the controls fed without this admixture. At the end of the 70-d fattening period, histological examination was carried out on selected individuals. The small intestine, liver, bursa of Fabricius, thymus, thyroid gland, pancreas, kidneys, heart, and skeletal muscle were observed on paraffin sections stained with hematoxylin and eosin. Cell proliferation was assessed in the liver and small intestine by means of bromodeoxyuridine labeling. The exposure to avoparcine resulted in a decreased cell proliferation in both tissues when compared to controls. In addition, hypertrophy of the hepatocytes and development of reactive lymphoid tissue in the bursa of Fabricius, which occurred in the controls, were absent in the treated animals. These observations indicate that the growth-promoting effect of avoparcine is related to a restriction in the host animals of responses to intestinal bacteria. No adverse pathological changes were observed in the examined tissues, indicating that avoparcine was well tolerated.

Lipid metabolism in anaerobic ecosystems

In anaerobic ecosystems, acyl lipids are initially hydrolyzed by microbial lipases with the release of free fatty acids. Glycerol, galactose, choline, and other non-fatty acid components released during hydrolysis are fermented to volatile fatty acids by the fermentative bacteria. Fatty acids are not degraded further in the rumen or other parts of the digestive tract but are subjected to extensive biohydrogenation especially in the rumen. However, in environments such as sediments and waste digestors, which have long retention times, both long and short chain fatty acids are beta-oxidized to acetate by a special group of bacteria, the H2-producing syntrophs. Long chain fatty acids can also be degraded by alpha-oxidation. Biotransformation of bile acids, cholesterol, and steroids by intestinal microorganisms is extensive. Many rumen bacteria have specific growth requirements for fatty acids such as n-valeric, iso-valeric, 2-methylbutyric, and iso-butyric acids. Some species have requirements for C13 to C18 straight-chain saturated or monoenoic fatty acids for growth.

The response of male chicken broilers to the dietary addition of virginiamycin

Two replicate trials, each involving 400 Arbor Acre male broiler chicks, were conducted to determine the effect of virginiamycin as a growth promoter when added to either the feed or drinking water. A control group received no growth promoter while one treatment group was provided a diet containing 11 mg of virginiamycin/kg. Another treatment group was provided drinking water containing virginiamycin in amounts calculated to ensure equivalent or one-half equivalent intake of the antibiotic. Virginiamycin supplementation had no significant (P greater than .05) effect on mortality or feed conversion ratios, regardless of the mode of administration. Body weights at 21 days of age but not at 42 days of age were significantly (P less than .05) heavier for broilers receiving virginiamycin via the drinking water. The inclusion of virginiamycin in the feed failed to improve body weights at either 21 or 42 days of age.

Influence of Virginiamycin on yield of broilers fed four levels of energy

An experiment was conducted to determine the effect of dietary Virginiamycin on processing yields of broilers fed four levels of energy. Body weights (catch, slaughter) and carcass weights (dry shell and ready-to-cook) were recorded. Shrink (holding weight loss), water uptake, shell yield, and ready-to-cook yield of the carcasses were calculated. Body weights were higher at higher energy levels and with addition of Virginiamycin to the diets. Weight loss due to shrink declined from 5.39 to 3.89% at higher dietary energy levels, but shrink was not affected by Virginiamycin. Water uptake was significantly higher for carcasses of birds fed the lowest dietary energy level (3.49%) than for carcasses of birds fed the two highest energy levels (2.89 and 3.03%); but differences among water uptake of carcasses of birds fed the three highest energy levels were not significant. Water uptake was unaffected by Virginiamycin. Increasing the dietary energy level resulted in higher ready-to-cook yields, from 61.7% yield at 2,271 kcal ME/kg to 65.4% yield at 2,953 kcal ME/kg. Yield was increased from 63.3 to 64.0% (P less than .01) by dietary Virginiamycin.

A differential response in turkey poults to various antibiotics in diets designed to be deficient or adequate in certain essential nutrients

Two experiments, each consisting of two trials, were conducted with day-old Nicholas Large White turkey poults to compare the effectiveness of four antibiotics for growth promotion and the utilization of sulfur amino acids. A corn-soybean meal basal diet that contained no supplemental methionine, choline, or inorganic sulfate was used in order to furnish nutritional stress. The diet was calculated to contain 25.4% protein, .448% methionine, .403% cystine, 1014 mg/kg choline, and 2990 kcal metabolizable energy/kg. In Experiment 1, a 2 X 4 factorial arrangement of treatments was used. This included two levels, (0% (control) and .18%), of supplemental DL-methionine and no antibiotic or bacitracin MD, flavomycin, or virginiamycin; antibiotics were fed at 50, 2, and 20 g/ton, respectively. In Experiment 2, lincomycin also was included as a treatment (at 4 g per ton) resulting in a 2 X 5 factorial arrangement of treatments. Only the addition of Virginiamycin to the control diet in Experiment 1 resulted in significantly increased body weights. Supplementation by .18% methionine increased body weights and feed efficiency. In addition, all three antibiotics increased body weights significantly when added to the .18% methionine diets. Feed efficiency values were improved by all four antibiotics at both methionine levels. In Experiment 2, increases in body weights similar to those in Experiment 1 were obtained with the addition of .18% methionine to the basal diets. Addition of lincomycin and virginiamycin improved body weights and feed efficiencies in the presence and absence of supplemental methionine.

Influence of virginiamycin on broilers fed four levels of energy

An experiment was conducted with broiler chicks to determine the influence of Virginiamycin on chicks fed diets with four levels of energy. Addition of the Virginiamycin to the diet resulted in significantly improved body weight and feed efficiency at all levels of energy. The greatest improvement was obtained at the lowest level of energy. Addition of Virginiamycin to the diet decreased the energy required to produce a unit of body weight.

Virginiamycin and laying hen performance

Two experiments were conducted for five 28-day periods each. In Experiments 1 and 2, Hyline W-36 hens, 36 and 26 weeks of age, respectively, were used. Experiment 1 was designed to measure the effect of virginiamycin on hen performance and egg characteristics when supplementing a diet having low pigmentation potential. In Experiment 2, the diet contained 3% added fat with 0, 10, and 20 ppm virginiamycin. In Experiment 1, virginiamycin-supplemented hens showed increased (P less than or equal to .05) egg production, body weight, and improved feed efficiency. When egg production and feed efficiency were ranked by quartiles within the control and virginiamycin-supplemented groups, virginiamycin was shown to benefit only the poorer producing hens. In Experiment 2, added fat improved feed efficiency; however, the response to virginiamycin, as observed in Experiment 1, did not occur.

Virginiamycin and broiler performance

Two experiments were conducted with broilers to determine the effect of Virginiamycin supplementation on performance and shank pigmentation. Virginiamycin supplementation at 10 ppm resulted in significantly increased body weights in both experiments. Feed efficiency was significantly improved in Experiment 1 by the supplementation of 5 and 10 ppm Virginiamycin. In Experiment 2, 20 ppm Virginiamycin was included and resulted in no greater response than that observed at 10 ppm. Pigmentation values as measured by a reflectance colorimeter and Roche color fan favored (P less than or equal to .05) Virginiamycin supplementation in both experiments. Data indicated that when the diet was supplemented with Virginiamycin an increase in the utilization of xanthophyll resulted. Mortality was not influenced by dietary treatment.

Stimulation of L-tryptophan transport by di- and polysaccharides in the small intestine of chicks

In in vivo and in vitro experiments the effect of various carbohydrates on the absorption of L-tryptophan in the chick small intestine was investigated. On feeding the chicks with semisynthetic diet containing 58.5% of carbohydrates a stimulatory effect of glucose, particularly of starch and saccharose, on the entry of L-tryptophan into the portal vein from the chick gastrointestinal tract has been found. Using an in vitro technique the activating effect of starch and disaccharides (maltose, saccharose) on the intestinal transport of L-tryptophan was detected while monosaccharides (glucose, fructose) at different concentrations had no effect on this process or inhibited it. The possibility that energy of disaccharide hydrolysis is used to stimulate transport process is discussed.

The response of cage-reared cockerels to dietary medication with growth promoters. I. Size and consistency of the response

Day-old cockerels were used to examine the growth responses obtained when 50 ppm procaine penicillin, 25 ppm zinc bacitracin, or 20 ppm nitrovin were administered in a wheat-based diet. The birds were fed ad libitum from one day of age a plain or supplemented diet in a series of 10, 21, and 56-day tests conducted between 1971 and 1974. Growth responses, measured by improvement in the live weight gain and feed conversion, were obtained with each treatment, consistently over each annual period. The penicillin and zinc bacitracin gave maximal differences in live weight gain compared with the controls before 14 days of age and, possibly, before 7 days of age, whereas the maximal response to treatment with nitrovin occurred after 14 days of age.

Effect of antibiotics on intestinal absorption in mice

1. The effects of dietary antibiotics (penicillin, neomycin or terramycin) on the absorption of D-glucose, D-galactose, L-arginine or L-histidine by the mouse were investigated by using sacs of entire everted ileum.

2. Compared with the controls, there was generally an increased absorption of all these solutes. Tissue uptake of the solutes remained unaltered. The inward movement of water into the sacs was increased but was generally independent of solute transport.

3. The body-weight decreased slightly and caecal weight increased with penicillin only. The weight of the small intestine decreased with the different antibiotics, and the gut wall became thinner. Faecal fat increased slightly, but not significantly, with neomycin only. Water intake decreased with the different antibiotics.